Delphi-based Spanish consensus on the use of long-acting growth hormone in pediatric growth hormone deficiency: recommendations from the ConverGHe Working Group
This is the first Delphi consensus to provide national-level guidance on integrating LAGH into pediatric GHD care, offering practical recommendations based on current evidence and national expert opinion. Future long-term real-world experience will contribute to address questions regarding long-term efficacy and safety, and practice-related points such as indication and monitoring.
Authors
- Lidia Castro-Feijóo
- Diego Yeste (ORCID: https://orcid.org/0000-0002-6620-6525)
- Marta Ramon‐Krauel (ORCID: https://orcid.org/0000-0003-3027-9105)
- I. González Casado (ORCID: https://orcid.org/0000-0001-7447-2914)
- Diana Primiano
- J.I. Labarta-Aizpún (ORCID: https://orcid.org/0000-0002-2319-5096)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital Sant Joan de Déu Barcelona (ES)
- Hospital Universitario La Paz (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
- Pfizer (Spain) (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-12-04
- DOI
- https://doi.org/10.3389/fendo.2025.1718161
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer